A new trading day began on Friday, with Intensity Therapeutics Inc (NASDAQ: INTS) stock price down -44.68% from the previous day of trading, before settling in for the closing price of $1.32. INTS’s price has ranged from $0.19 to $3.40 over the past 52 weeks.
Annual sales at Healthcare sector company slipped by -23.29% over the past five years. Meanwhile, its annual earnings per share averaged 67.74%. With a float of $43.80 million, this company’s outstanding shares have now reached $49.06 million.
Let’s look at the performance matrix of the company that is accounted for 16 employees.
Intensity Therapeutics Inc (INTS) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Intensity Therapeutics Inc is 10.72%, while institutional ownership is 4.12%.
Intensity Therapeutics Inc (INTS) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.25 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 67.74% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.66% during the next five years compared to -23.29% drop over the previous five years of trading.
Intensity Therapeutics Inc (NASDAQ: INTS) Trading Performance Indicators
Here are Intensity Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.83, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.23 in one year’s time.
Technical Analysis of Intensity Therapeutics Inc (INTS)
Intensity Therapeutics Inc (NASDAQ: INTS) saw its 5-day average volume 327.57 million, a positive change from its year-to-date volume of 10.1 million. As of the previous 9 days, the stock’s Stochastic %D was 57.75%.
During the past 100 days, Intensity Therapeutics Inc’s (INTS) raw stochastic average was set at 35.05%, which indicates a significant increase from 33.39% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1336 in the past 14 days, which was higher than the 0.0465 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2971, while its 200-day Moving Average is $0.9563. Nevertheless, the first resistance level for the watch stands at $1.0201 in the near term. At $1.3101, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4701. If the price goes on to break the first support level at $0.5701, it is likely to go to the next support level at $0.4101. The third support level lies at $0.1201 if the price breaches the second support level.
Intensity Therapeutics Inc (NASDAQ: INTS) Key Stats
With a market capitalization of 35.82 million, the company has a total of 49,055K Shares Outstanding. Currently, annual sales are 0 K while annual income is -16,270 K. The company’s previous quarter sales were 0 K while its latest quarter income was -2,540 K.
